Call us at (888) 828-2206. We'll help answer any questions you may have.
PBCAR269A is a BCMA targeted allogeneic (donor-derived) CAR T-cell therapy being developed for multiple myeloma patients.
September 02, 2020
You can give us a call at (888) 828-2206 or create your account to add this treatment to your list of favorites. We'll send you alerts when this treatment is updated.
Create My Account